Ventripoint Diagnostics

As Ventripoint Diagnostics embarks on a new chapter of market expansion, reliable distribution is a prime focus. Here are some of our trusted distributors:

🔹 970 Equipment
🔹 Meditek Lifesciences
🔹 Coviix Biosciences
🔹 Alpha Surgical Solutions
🔹 Cardiologic Limited
🔹 Angiopro GmbH

See the full list of our partners: https://loom.ly/XTyHMvE

The software as a medical device market (SaMD) may reach $86.4 billion in market value by 2027 with a compound annual growth rate of 21.9%, according to an analysis by The Insight Partners. SaMD is becoming increasingly popular as they can be used on existing hardware such as workstations. The FDA and European Commission have both already acknowledged its potential to change the medical landscape.

Know where Ventripoint Diagnostics fits into this: https://loom.ly/_eYnMFU

In 2022, Ventripoint investments in sales and marketing infrastructure included:

• Key hires of strategic sales leaders to cover the US, UK, and Europe.
• Hires in clinical applications and technical support to support the sales team, including direct sales and distributors.
• Partnerships with 11 distributors to cover US, UK, and Europe markets; all with a focus on cardiology therapy bringing the sales team to 33 representatives.
• Investing in marketing initiatives to increase awareness of VMS, including attending and sponsoring 12 medical conferences.

Learn how we build our presence in key markets: https://loom.ly/s1Da6xE

Ease of use and product support are priorities for us as drivers of customer satisfaction. That is why Ventripoint Diagnostics makes sure that support documentation and product information are available on our website in different languages following the extent of our distribution area.

See what draws practitioners to our products and how you can be a part of it: https://loom.ly/s1Da6xE